A review on targeted therapies for lung cancer

A review on targeted therapies for lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Detaylı Bibliyografya
Yazar:	Ashraf, Anushey
Diğer Yazarlar:	Khan, Tanisha Tabassum Sayka
Materyal Türü:	Tez
Dil:	English
Baskı/Yayın Bilgisi:	Brac University 2023
Konular:	Lung cancer Antibodies Targeted therapy Vaccines Lung cancer > Treatment
Online Erişim:	http://hdl.handle.net/10361/19353

Benzer Materyaller

Immunotherapy in the Management of Lung Cancer
Yazar:: Tasnim, Humayra
Baskı/Yayın Bilgisi: (2022)

Potential of liposomes for the treatment of lung cancer- a review
Yazar:: Mim, Shanzida
Baskı/Yayın Bilgisi: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Yazar:: Tania, Umme
Baskı/Yayın Bilgisi: (2023)

Molecules associated with the development of lung cancer
Yazar:: Rahman, Adree, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Yazar:: Paul, Pulock
Baskı/Yayın Bilgisi: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
Yazar:: Rahman, Tasnim
Baskı/Yayın Bilgisi: (2024)

A review on recent advances in drugs for lung cancer treatment
Yazar:: Noor, Fouzia
Baskı/Yayın Bilgisi: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
Yazar:: Jeba, Joynob
Baskı/Yayın Bilgisi: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Yazar:: Razna, Amrin Islam
Baskı/Yayın Bilgisi: (2019)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Yazar:: Flora, Sanzida Alam
Baskı/Yayın Bilgisi: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
Yazar:: Pial, Sazia Afrin
Baskı/Yayın Bilgisi: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
Yazar:: Zangmo, Thinley
Baskı/Yayın Bilgisi: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
Yazar:: Hoque, Ismoth Ara
Baskı/Yayın Bilgisi: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
Yazar:: Shabnam, Musharrat
Baskı/Yayın Bilgisi: (2018)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
Yazar:: Bristy, Israt Zerin
Baskı/Yayın Bilgisi: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
Yazar:: Alam, Kazi Tasnuva
Baskı/Yayın Bilgisi: (2022)

Lung cancer detection and classification using machine learning
Yazar:: Arefin, Mahbubul, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
Yazar:: Das, Reshita
Baskı/Yayın Bilgisi: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
Yazar:: Jahan, Nusrat
Baskı/Yayın Bilgisi: (2024)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
Yazar:: Nandy, Aditi
Baskı/Yayın Bilgisi: (2022)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
Yazar:: Mukti, Roushney Fatima, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
Yazar:: Kamal, Tasnova
Baskı/Yayın Bilgisi: (2019)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
Yazar:: Nahar, Kamrun
Baskı/Yayın Bilgisi: (2023)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Yazar:: Ratu, Tabassum
Baskı/Yayın Bilgisi: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
Yazar:: Parvez, Safi
Baskı/Yayın Bilgisi: (2023)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Yazar:: Meem, Manila
Baskı/Yayın Bilgisi: (2023)

A comprehensive review on drug repurposing in cancer treatment
Yazar:: Sarkar, Onusree
Baskı/Yayın Bilgisi: (2024)

The impact of cell penetrating peptides in prospective cancer therapy: a review
Yazar:: Nashrah, Zannatul
Baskı/Yayın Bilgisi: (2023)

Breast cancer therapy through Liposomal drug delivery system
Yazar:: Ome, Nusrat Jahan
Baskı/Yayın Bilgisi: (2024)

Trend in approval of targeted biologics in the last two decades
Yazar:: Siddika, Khadiza
Baskı/Yayın Bilgisi: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
Yazar:: Hasan, Amit
Baskı/Yayın Bilgisi: (2024)

Current practice and approaches of immunotherapy in Cancer treatment
Yazar:: Khondokar, Faiza
Baskı/Yayın Bilgisi: (2022)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Yazar:: Karim, Samia Binte
Baskı/Yayın Bilgisi: (2024)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
Yazar:: Alam, Tahera
Baskı/Yayın Bilgisi: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
Yazar:: Abir, Shifaty Nur
Baskı/Yayın Bilgisi: (2024)

A review paper on Nanotechnology based strategies in the treatment of cancer
Yazar:: Rahman, Samia
Baskı/Yayın Bilgisi: (2022)

A review on potential of PARP inhibitors in the treatment of prostate cancer
Yazar:: Islam, Saidul
Baskı/Yayın Bilgisi: (2022)

The uses of bacteria in cancer therapy
Yazar:: Saha, Shimul, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
Yazar:: Chakraborty, Anuradha
Baskı/Yayın Bilgisi: (2024)

Concepts and challenges of biosimilars to mitigate the oncology drug expenses
Yazar:: Tania, Umme
Baskı/Yayın Bilgisi: (2021)